Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal Sells 30,000 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal sold 30,000 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the transaction, the director now owns 126,843 shares in the company, valued at $1,212,619.08. The trade was a 19.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Viemed Healthcare Price Performance

VMD stock opened at $9.06 on Friday. The company has a fifty day moving average price of $8.31 and a 200-day moving average price of $7.53. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $10.44. The company has a market capitalization of $352.80 million, a P/E ratio of 33.56 and a beta of 1.43. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The company had revenue of $58.00 million for the quarter.

Institutional Trading of Viemed Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Wasatch Advisors LP grew its holdings in shares of Viemed Healthcare by 19.6% during the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after acquiring an additional 303,277 shares during the period. Raffles Associates LP raised its holdings in Viemed Healthcare by 11.0% in the 3rd quarter. Raffles Associates LP now owns 402,691 shares of the company’s stock worth $2,952,000 after acquiring an additional 40,000 shares during the last quarter. PDT Partners LLC bought a new position in shares of Viemed Healthcare during the third quarter valued at $78,000. Walleye Capital LLC purchased a new position in shares of Viemed Healthcare during the third quarter valued at approximately $87,000. Finally, Martingale Asset Management L P boosted its stake in shares of Viemed Healthcare by 28.5% in the 3rd quarter. Martingale Asset Management L P now owns 31,385 shares of the company’s stock worth $230,000 after buying an additional 6,965 shares during the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.